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Background: RNA-seq and microarray are the two popular methods employed for genome-wide transcriptome
profiling. Current comparison studies have shown that transcriptome quantified by these two methods correlated
well. However, none of them have addressed if they complement each other, considering the strengths and the
limitations inherent with them. The pivotal requirement to address this question is the knowledge of a well known
data set. In this regard, HrpX regulome from pathogenic bacteria serves as an ideal choice as the target genes of
HrpX transcription factor are well studied due to their central role in pathogenicity.
Results: We compared the performance of RNA-seq and microarray in their ability to detect known HrpX target
genes by profiling the transcriptome from the wild-type and the hrpX mutant strains of γ-Proteobacterium
Xanthomonas citri subsp. citri. Our comparative analysis indicated that gene expression levels quantified by RNA-seq
and microarray well-correlated both at absolute as well as relative levels (Spearman correlation-coefficient, rs > 0.76).
Further, the expression levels quantified by RNA-seq and microarray for the significantly differentially expressed
genes (DEGs) also well-correlated with qRT-PCR based quantification (rs = 0.58 to 0.94). Finally, in addition to the 55
newly identified DEGs, 72% of the already known HrpX target genes were detected by both RNA-seq and
microarray, while, the remaining 28% could only be detected by either one of the methods.
Conclusions: This study has significantly advanced our understanding of the regulome of the critical transcriptional
factor HrpX. RNA-seq and microarray together provide a more comprehensive picture of HrpX regulome by
uniquely identifying new DEGs. Our study demonstrated that RNA-seq and microarray complement each other in
transcriptome profiling.
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Transcriptome of an organism represents the entire rep-
ertoire of transcripts encoded by the genes as a pheno-
typic response to the condition in which they exist. The
sheer ability to simultaneously quantify the expression
levels for a vast number of genes has revolutionized the
biomedical research, facilitating the analysis of global
gene expression patterns at the genome-wide scale [1].
In the past decade, there has been a tremendous pro-
gress in the development of methods to deduce and
quantify the gene expression levels at the whole tran-
scriptome level [1]. Among the several transcriptome* Correspondence: nianwang@ufl.edu
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reproduction in any medium, provided the orprofiling methods, RNA-seq and DNA microarray stand
out as the two widely used genome-wide gene expression
quantification methods [1-17].
RNA-seq method involves the conversion of isolated
transcripts into the complementary DNA (cDNA), which
is then directly sequenced in a massively parallel deep-
sequencing-based approach [18]. By mapping the resulting
short sequencing reads onto the reference genome, the ex-
pression levels of genes relative to the condition of interest
or absolute levels can be quantified [9,11]. This method
has been implemented in different platforms like Illumi-
na’s Genome Analyzer, Roche 454 Genome Sequence, and
Applied Biosystems’ SOLiD [4]. On the other hand,
microarray is based on the hybridization of specimen tar-
get strands onto the immobilized complementary probe
strands. For example, in a two-color microarray, transcriptsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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distinct fluorescent dyes while being converted to
cDNA. These labeled samples are then hybridized to
the immobilized complementary probe strands in an
array representing the genes. By measuring the light in-
tensity of the distinct fluorescent dyes, the relative
abundance of each transcript in the two different con-
ditions can be measured [8,12,13,17,19,20]. Affymetrix
and Agilent are the two prevalent platforms in micro-
array technology [2,14].
Even though, initially microarray has been instrumental
in whole transcriptome analysis, currently RNA-seq is
becoming a preferred method of choice, since it is con-
sidered to effectively surmount the limitations of micro-
array [1,21-23]. RNA-seq technology, unlike microarray,
does not depend on the prerequisite knowledge of the
reference transcriptome [24]. Further, RNA-seq data
contains very low background signal, a higher dynamic
range of expression levels, and also relatively small
amount of total RNA required for quantification, when
compared to microarray [1,23]. Despite these advan-
tages, the efficiency of RNA-seq is marred with the
problem of overwhelming amount of ribosomal RNA
(rRNA) in the data, short reads, less base accuracy, and
variation of read density along the length of the tran-
script, posing a challenge for this high-throughput
method [21,25,26]. However, in spite of their strengths
and limitations, RNA-seq and microarray have become
the default popular methods of choices for genome-
wide transcriptome studies [1,2,23].
Currently several studies have been conducted to
compare the performance of RNA-seq and microarray
in quantifying the expression level of genes, by focusing
on various aspects like reproducibility, accuracy, statis-
tical issues, technical and biological variabilities
[1,15,21,27-30]. The main conclusion from these studies
has been that the expression levels quantified by these
two methods correlated to a large extent, and overall
favored the RNA-seq because of high reproducibility, ac-
curacy, and dynamic range [27,29]. However, none of
these comparison studies have addressed if these two
methods complement each other in transcriptome profil-
ing given the strengths and limitations associated with
them. In order to address this question, we require an
already well characterized dataset. The HrpX regulome
from Xanthomonas citri subsp. citri (Xcc) serves as an
ideal data model in this regard [31-33]. Xcc is a causal
agent of citrus canker, one of the serious and destructive
diseases in citrus that is resulting in significant losses to
citrus industry worldwide [34], while HrpX is a key glo-
bal transcription factor that regulates the expression of
hrp (hypersensitive response and pathogenicity) cluster
of genes, which are considered as the major pathogen-
icity factors [31,35]. HrpX contains AraC-type of DNAbinding domain, which specifically recognizes the plant-
inducible promoter (PIP) box (TTCGC-N15-TTCGC)
and imperfect PIP box (TTCGC-N8-TTCGT) present in
the cis-regulatory regions of hrp gene cluster [36-38].
Since HrpX has a key role in pathogenicity, tremendous
progress has been made in cataloguing the target genes
of HrpX [39-45]. We therefore assessed the performance
of RNA-seq and microarray in their ability to detect
known HrpX target genes. We chose Illumina and Agi-
lent as the corresponding platforms for RNA-seq and
microarray, as they are the most popular platforms for
these technologies [2,4].Results
In order to uncover the regulome of HrpX transcription
regulator by profiling the wild-type and the hrpX mutant
strains transcriptome, we had designed a microarray
chip covering the whole genome under Agilent platform
in our previous study [33]. Here, we conducted genome-
wide transcriptome profiling of these two strains by
RNA-seq and compared the results to the previously
published microarray data, to assess the performance of
these two methods. Further, to avoid technical variation
associated with RNA isolation, we used the aliquots
from the same total RNA samples used for microarray
experiments also for RNA-seq.
We obtained 16,431,283, 17,289,220, 18,124,120 sequence
reads for the wild-type and 15,084,955, 17,831,920, and
18,115,115 for the hrpX mutant strain with a median
sequence length of 74-base pairs (bp) (Additional file 1:
Table S1). Raw reads often have high sequencing errors,
especially in the 30 end where there is a high chance of
sequencing errors to occur [46]. We therefore filtered the
reads for high quality ones by trimming off the base pairs
with low quality score assigned to them during down-
line processing of RNA-seq. More than 90% of the reads
passed the quality filter, as a result, the median sequence
length of quality filtered reads subsequently dropped to
68-bp (Additional file 1: Table S1). We then mapped
these high quality trimmed reads on to the Xcc genome.
Approximately more than 90% of the reads could be
mapped on to the reference genome, indicating good
sequence coverage (Additional file 1: Table S1). Overall
~97% of the annotated genes had more than one read
mapped, while merely ~3% of the annotated genes had
no reads mapped, indicating good sequencing depth.
Further, we also observed a difference in the sequence
coverage between the chromosome and the two en-
dogenous plasmids of Xcc. Annotated coding genes
from the chromosome with a size of 5.18 mega base
pairs (Mb) had 98% sequence coverage, whereas, it
was 78% for plasmid pXAC64 with a size of 0.06 Mb,
and relatively lower with only 62% sequence
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(Additional file 1: Table S2).
Comparison at absolute levels of expression
RNA-seq had coverage for 4323 genes with one or
more reads mapped, while by microarray 4349 genes
were assigned the fluorescence intensity values after
the background correction. Among these 4312 genes
(~99% of the total genes) were common to both meth-
ods, while merely 37 (0.8%) and 11 genes (0.2%) were
uniquely called by microarray and RNA-seq respectively
(Additional file 1: Tables S2 and S3; Additional file 2: Fig-
ure FS1). We compared the absolute levels of gene ex-
pression in terms of RNA-seq counts and microarray
fluorescence intensities for all the listed genes called by
both the methods. These two independent measures of
transcript abundance associated with each gene for all
the biological replicates from the wild-type and the hrpX
mutant strains were compared separately. The resulting
correlation was mapped as a scatter plot, with an average
number of counts from Illumina sequencing against the
normalized fluorescence intensities from Agilent arrays
for each gene in the wild-type (Figure 1A) as well as in
the hrpX mutant (Figure 1B). Absolute levels of gene ex-
pression correlated well, when estimated in terms of
Spearman’s correlation coefficient (rs) with 0.78 (p-value
< 0.0001) for the wild-type and 0.80 (p-value < 0.0001)

























Figure 1 Comparison of absolute levels of gene expression by RNA-s
hrpX mutant, the correlation between normalized fluorescence intensities o
represents the average values for each gene from all the biological replicat
comparison. Lower panel shows rs between normalized fluorescence inten
all the combination of biological replicates for the (C) wild-type, and (D) th
where green color represents low rs value, while red represents highest rs vprevious reports that expression levels measured by
microarray and RNA-seq had correlations ranging be-
tween 0.62 and 0.8 for prokaryotic and eukaryotic data-
sets [18,28,29]. However, there seems to be little or no
correlation for the genes with low level of expression.
We further estimated the correlation for the subset of
genes with fluorescence intensity values ≤100 assigned by
microarray (~360 genes) with the corresponding expres-
sion levels determined by RNA-seq. This subset of genes
revealed a very poor rs of 0.2 (p-value <0.0002) and 0.3
(p-value <0.0001) for the wild-type and the hrpX mutant
strains respectively. Although the expression levels of
these genes did not change much according to micro-
array, RNA-seq reported them to have different expres-
sion levels. This may be attributed to the high sensitivity
of RNA-seq method.
We further estimated the correlation between all the
combinations of biological replicates for the wild-type
and the hrpX mutant strains independently. The result-
ing rs values of these comparisons are represented in the
form of heat maps, for the wild-type (Figure 1C) and the
hrpX mutant strains (Figure 1D), which provide a global
view of these correlations. Overall, on an average the
wild-type with rs = 0.76 (p-value < 0.0001) and the hrpX
mutant with rs = 0.78 (p-value < 0.0001) were observed
for the biological replicates from all the correlation com-
binations. This level of comparison strongly suggested























eq and microarray. Upper panel shows for the (A) wild-type and (B)
f Agilent microarray with the RNA-seq counts from Illumina. Each dot
es. Spearman’s correlation coefficient (rs) is indicated for each
sities of Agilent microarray with the RNA-seq counts from Illumina for
e hrpX mutant. The rs values are plotted in the form of a heat map,
alue. The dendrogram provides a hierarchical clustering.
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lated, but were also highly reproducible, in spite of the
technical as well as the biological variability associated
with the quantifications.
Comparison at relative levels of expression
We also compared the performance of these two meth-
ods at relative level of gene expression. For this purpose,
we first computed the relative expression level of genes
in terms of fold-change (FC) for the hrpX mutant in re-
lation to the wild-type strain, along with p-values to de-
note the statistical significance and false discovery rate
(FDR), for having a good control over the false positives
rate. We compared the relative expression levels for
4312 consensus genes both qualitatively and quantita-
tively, after transforming the FC values to logarithm base
2 (log2) scale without any statistical cut-off thresholds
(Additional file 1: Table S2). For the 2587 (~60% of the
consensus) genes, the expression levels agreed qualita-
tively, while 1725 (~40%) genes disagreed between the
two methods (Figure 2A). At this point, our comparison













Figure 2 Qualitative and quantitative comparison of relative levels of
wild-type strain, determined by RNA-seq and microarray methods. (A
change values for expression of 4312 genes by RNA-seq and microarray. (B
of log2FCs, determined by RNA-seq and microarray. Correlation between th
Frequency histogram showing the percentage of genes with the fold diffe
The lower panel D, E, and F are same as A, B, and C respectively, but for o
(FDR ≤ 5% and absolute log2 fold-change ≥ 0.6).is up- or down-regulated based on the sign of the log2
transformed FC values, but not necessarily on the FC
magnitude. We further illustrated the quantitative rela-
tionship of log2FC between RNA-seq and microarray
in the form of a scatter plot as shown in Figure 2B.
Genes with no change in expression levels in the wild-
type and the hrpX mutant strains (FC = 1) clustered
around log2FC of zero (log2 of one is zero) in the scat-
ter plot (Figure 2B). The rs between the log2FCs deter-
mined by RNA-seq and microarray was found to be
0.30 (p-value < 0.0001) (Figure 2B). This lower correl-
ation value indicated that the magnitude of FCs be-
tween the two methods differed largely that might be
due to the background noise resulting from the many
imperfections, which are inherent to the high-
throughput technologies [47,48].
The correlation coefficient provides an overall estimate
of correlation between the expression levels determined
by RNA-seq and microarray methods. However, this
does not zoom into the data in a detailed manner. For
instance, no information is provided about how much of
FC magnitude that actually differs between the twoF
C
gene expression in the hrpX mutant with respect to the
) Venn diagram showing the qualitative agreement in the log2 fold-
) Scatter plot showing the relative expression levels of genes in terms
e two methods is shown by Spearman’s correlation coefficient (rs). (C)
rence between RNA-seq and microarray, with a bin width of 0.5.
nly those genes that have passed the statistical cut-off threshold
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this aspect, we computed the fraction of genes deviating
in their FC magnitude values by dividing the FC magni-
tude value determined by RNA-seq with that of micro-
array (Figure 2C). Here, the fold difference of one
represents the fraction of genes that are determined to
have a FC magnitude of ± 0.5 (bin width) by both RNA-
seq and microarray methods. When we plotted this fre-
quency as a histogram for the whole 4312 consensus
genes, more than 75% of genes were found to have FC
magnitude values ± 0.5 by RNA-seq and microarray
methods. Since it is a relative expression comparison,
genes whose expression values did not change much in
the wild-type and the hrpX mutant strains, tend to have
FC values = 1. Subsequently, it is more sensible to con-
sider only differentially expressed set of genes for further
comparisons.
We therefore applied FDR ≤ 0.05 (5%) in conjunction
with FC (absolute log2FC ≥ 0.6) to filter the whole data
set. In total, 87 (2%) genes from RNA-seq and 64 (1.5%)
from microarray qualified at this cut-off threshold from
the 4312 consensus genes (Additional file 1: Table S4).
Together, 106 genes satisfied our selection criterion from
both the methods (Additional file 1: Table S4). Among
them 84 (79.2%) genes were up-regulated, while 22
(20.8%) genes were found to be down-regulated. Further,
45 (~42.45%) genes were common between both the
methods, whereas, 42 (39.63%) and 19 (~17.92%) genes
were uniquely detected by RNA-seq and microarray re-
spectively (Additional file 1: Table S4; Additional file 2:
Figure FS2). We further compared the FC values of the
45 consensus genes both qualitatively and quantitatively.
These genes qualitatively agreed 100% by having the
same trend of log2 transformed FC values by both RNA-
seq and microarray (Figure 2D). Likewise the quantita-
tive comparison was performed by estimating the correl-
ation between the magnitude of log2FC determined by
RNA-seq and microarray for the 45 consensus genes as
shown in Figure 2E. The magnitude of FC values be-
tween the two methods were found to be well correlated
(rs = 0.76, p-value < 0.0001), indicating that the same
trend of variation was observed in FC values between
the two methods without any dispersion. Thereby, the
magnitude of FC values determined by RNA-seq and
microarray agreed to a large extent for the 45 consensus
genes. In order to further pinpoint the deviation in the
FC magnitude quantified by the two methods, we plot-
ted the differences in the FC values determined by RNA-
seq with respect to microarray, and the percentage of
genes with that difference for the 45 consensus genes
(Figure 2F). Majority of the genes (~98%) were found to
have a magnitude of FC within the range of ≤ 1.5, while
for the remaining 2% of the genes, it was 4.7-times
higher in RNA-seq than the microarray basedquantification. Based on these comparisons, we con-
cluded that the relative gene expression levels quantified
by RNA-seq and microarray were consistent to a large
extent for the statistically differentially expressed set of
consensus genes.
Comparison with qRT-PCR
Traditionally, quantitative Reverse Transcription PCR
(qRT-PCR) is used to validate the gene expression levels
quantified by high-throughput technologies like RNA-
seq and microarray [49]. Therefore, we compared the
relative expression levels quantified by RNA-seq and
microarray by qRT-PCR for a subset of 43 (40.6%) genes
(Additional file 1: Table S5) that were randomly selected
from the 106 significantly differentially expressed genes.
Among them, 19 genes were found to be common be-
tween both the methods, 12 genes were unique to RNA-
seq, while remaining 12 genes were found to be unique
to microarray (Additional file 1: Table S4). The expres-
sion levels were found to be highly reliable for genes that
are determined to be significantly differentially expressed
by RNA-seq (rs = 0.94; p-value < 0.0001) as well as
microarray (rs = 0.97; p-value < 0.0001). For the consen-
sus genes, microarray had a slightly higher correlation
with qRT-PCR than RNA-seq (Figures 3A and 3B).
We further plotted the percentage of genes that
deviated in the magnitude of FC quantified by RNA-seq
and microarray with respect to qRT-PCR (Figures 3C
and 3D). For most of the genes, the magnitude of FC
quantified by RNA-seq and microarray were relatively
higher, when compared to qRT-PCR (fold difference >1).
Overall, the magnitude of FC quantified by RNA-seq
was in consistence with qRT-PCR based quantification
(Figure 3C). For microarray, the magnitude of FC was
observed to be consistent with qRT-PCR for a majority
of genes, however, we also noticed outlier genes with a
9-times higher FC magnitude (Figure 3D).
For the subset of 12 genes that were found to be
uniquely determined by RNA-seq, the magnitude of
FC quantified by RNA-seq correlated moderately with
qRT-PCR (rs = 0.58; p-value 0.05) (Figure 4A; Additional
file 1: Table S5). The 12 genes found to be uniquely
detected by microarray had a correlation of rs = 0.92
(p-value 0.002) with qRT-PCR (Figure 4B; Additional file 1:
Table S5). These correlations are slightly lower when com-
pared to the consensus genes (rs ≥ 0.94). This indicated
that the expression levels are more reliable for the genes
that are determined to be significantly differentially
expressed by both RNA-seq and microarray rather than by
any one method. Moreover, it also indicated that there is a
lot of variation in the magnitude of FC quantified by RNA-
seq and qRT-PCR. We further evaluated this variation
i.e. deviation from the magnitude of FC, by plotting the




Figure 3 Comparison of expression levels quantified by RNA-seq and microarray with qRT-PCR. (A) Comparison of expression levels
determined by RNA-seq with qRT-PCR. (B) Comparison of expression levels determined by microarray with qRT-PCR (C) Frequency histogram
showing the percentage of genes with the fold difference between RNA-seq and qRT-PCR, with a bin width of 0.5. (D) Frequency histogram




Figure 4 Comparison of expression levels of genes that are uniquely determined by RNA-seq and microarray with that of qRT-PCR.
Expression levels for the set of selected genes quantified by (A) RNA-seq, and (B) microarray with that of qRT-PCR. Frequency histogram showing
percentage of genes deviating from the magnitude of FC, quantified by RNA-seq (C), and microarray (D) with respect to qRT-PCR. Bin width of
0.5 and 0.05 are used respectively.
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unique to RNA-seq, we observed that none of them had
the same magnitude of FC, with 50% genes having 0 to
0.5-time lower and for the remaining 50% of the genes the
magnitude of FC was observed to be 2 to 3-time higher,
when compared to qRT-PCR (Figure 4C). Because of this
inconsistence in the magnitude of FC, the expression levels
are moderately correlated. For the genes unique to micro-
array, we observed a good consistence in the magnitude of
FC with qRT-PCR (Figure 4D).Comparison in terms of detection of genes encoding
T3SS and effectors
Extensive and detailed studies have been carried out
since past three decades in cataloguing the target genes
of HrpX in the genus Xanthomonas using various gen-
etic and biochemical methods [32,38,39,50-55]. HrpX is
known to regulate hrp gene cluster that encodes the type
III secretion system (T3SS) and effectors [31,56]. T3SS
are specialized macromolecular machinery that act as a
nano-injector to translocate the effector proteins into
the cytoplasm of host plant cells [50]. These translocated
effectors manipulate the host cellular processes by alter-
ing signal transduction, transcriptional activities like
suppression of basal plant defense responses, and pro-
tein turnover in host cells for the benefit of the pathogen
[50]. The T3SS machineries are evolutionarily conserved
across many Gram-negative animal- and plant-
pathogenic bacteria [57].
Xcc is comprised of 25 hrp genes, including 19 hrp-
conserved (hrc) and 6 hrp-associated (hpa) genes that
encode the T3SS [58]. These genes are clustered in a
~25 kb region spanning from 462712 to 488334 bp of
the genome [32]. We applied statistically significant dif-
ferentially expressed gene list that were derived from
RNA-seq and microarray methods to this cluster. We
counted for the number of known hrp cluster genes,
which passed the FC and FDR cut-off thresholds from
RNA-seq and microarray methods (Table 1). Among the
25 hrp cluster genes, 16 (64%) were detected by both
RNA-seq and microarray methods. Six genes were found
to be uniquely detected by microarray, whereas, none
uniquely detected by RNA-seq (Table 1). Three genes
namely, hrcC, hpa2, and hpaA could not pass our statis-
tical cut-off criteria by any of the methods, although
they followed the same qualitative expression pattern.
We further quantified the deviation in the magnitude of
FC for the 16 known hrp genes, found in consensus be-
tween RNA-seq and microarray (Figure 5A). The magni-
tude of FC for 5% genes found to be same, while for the
remaining 95% genes it was found to be between 1.2 to
1.8-time higher in RNA-seq than in microarray. Even
though, microarray overall detected more genes fromhrp cluster, RNA-seq reported higher magnitude of FC
(Table 1).
Xcc also encodes 25 putative effector genes regulated
by HrpX, which meditate the interaction with the host
plant, hence determine the host specificity [55]. Since
XAC2785, XAC1210 and XAC1209 were considered as
pseudo or inactive genes, they were excluded from our
analysis. We tabulated how many of these genes were
detected by RNA-seq and microarray methods with their
corresponding log2FC values along with p-value and
FDR from the respective methods (Table 2). In total, 10
(45.5%) genes were detected by both the methods. RNA-
seq and microarray uniquely detected one and three
genes respectively. The remaining 9 genes (36.4%) were
neither detected by RNA-seq nor by microarray, since
they could not pass both the FC and FDR cut-offs
(Table 2). For the 10 consensus genes, we calculated the
fold differences in the magnitude of FC quantified by
RNA-seq with respect to microarray. None of the genes
had the same magnitude of FC between the two meth-
ods. Microarray estimated higher magnitude of FC for
~64% genes than RNA-seq, while RNA-seq estimated
1.2 to 1.8-time higher magnitude of FC for the
remaining ~36% genes (Figure 5B). In contrast to hrp
gene cluster, where microarray qualitatively outper-
formed RNA-seq in its ability to detect more genes, here
RNA-seq complemented quantitatively with higher con-
fidence by reporting higher magnitude of FCs. Thereby,
for the effector gene data set, RNA-seq and microarray
complemented each other both qualitatively as well as
quantitatively.
Overall, considering T3SS and effector genes, in total
there are 47 genes, from which, 26 genes (55%) were
detected by both RNA-seq and microarray (Tables 1 and
2). RNA-seq uniquely detected 1 gene (2%), whereas,
microarray detected 9 genes (19%). Remaining 11 genes
(23%) were not detected by either one of the methods by
failing to pass the cut-off threshold (Tables 1 and 2).
Further, considering only the genes that are detected by
at least one method, 72% of the known were detected by
both methods, while remaining 28% were detected by ei-
ther one of the methods.Genes uniquely detected by RNA-seq and microarray
Among the 87 statistically significant differentially
expressed genes from RNA-seq, 42 (39.63%) genes were
found to be uniquely detected by this method (Add-
itional file 2: Figure FS2). Of these 42 genes, 17 were
found to be down-regulated, while 25 were up-regulated
(Additional file 1: Table S4). Nearly 98% of these genes
(41 of 42 unique) could not pass the FC cut-off thresh-
old by microarray. The only exception is the gene fliO
(XAC1945) that encodes a flagellar protein for flagellum
apparatus, which passed the FC cut-off, but failed with
Table 1 Summary of Type III secretion system (T3SS) hrp cluster genes detected by RNA-seq and microarray
Locus Tag Gene Symbol RNA-seq Microarray Detected by
log2FC p-value FDR log2FC p-value FDR
XAC0412 hrcN −2.2355 7.66E-09 1.27E-06 −0.8217 0.00E+00 0.00E+00 †
XAC0409 hrcJ −3.1488 4.20E-15 1.40E-12 −2.1840 0.00E+00 0.00E+00 †
XAC0406 hrcU −2.6729 1.01E-13 2.56E-11 −1.0507 0.00E+00 0.00E+00 †
XAC0405 hrcV −1.5755 3.27E-08 4.88E-06 −0.8427 4.00E-05 2.58E-03 †
XAC0407 hrpB1 −3.9638 7.53E-28 3.61E-25 −2.8603 0.00E+00 0.00E+00 †
XAC0408 hrpB2 −2.8155 2.48E-09 4.67E-07 −1.9507 0.00E+00 0.00E+00 †
XAC0410 hrpB4 −1.9274 7.42E-05 6.05E-03 −1.5237 0.00E+00 0.00E+00 †
XAC0403 hrcQ −2.0615 6.36E-07 7.64E-05 −0.8647 0.00E+00 0.00E+00 †
XAC0402 hrcR −1.7123 4.73E-06 5.53E-04 −0.8677 0.00E+00 0.00E+00 †
XAC0399 hrpD5 −1.7287 2.67E-10 5.50E-08 −1.5487 0.00E+00 0.00E+00 †
XAC0398 hrpD6 −1.5446 5.85E-07 7.43E-05 −1.6347 0.00E+00 0.00E+00 †
XAC0397 hrpE −2.1535 7.67E-16 2.76E-13 −1.8163 0.00E+00 0.00E+00 †
XAC0394 hrpF −2.0517 7.04E-15 2.17E-12 −1.2113 0.00E+00 0.00E+00 †
XAC0416 hpa1 −5.0096 1.49E-51 1.29E-48 −4.2917 0.00E+00 0.00E+00 †
XAC0396 hpaB −1.5429 1.56E-07 2.11E-05 −1.2527 0.00E+00 0.00E+00 †
XAC0393 hpaF −0.9235 1.96E-04 1.34E-02 −0.6083 1.00E-05 8.10E-04 †
XAC0411 hrpB5 −1.9690 3.92E-03 1.38E-01 −0.8457 0.00E+00 0.00E+00 ψ
XAC0401 hrcS −1.0156 4.00E-02 4.71E-01 −1.0837 0.00E+00 0.00E+00 ψ
XAC0404 hpaP −1.2673 1.10E-02 2.74E-01 −1.1110 0.00E+00 0.00E+00 ψ
XAC0395 XAC0395 −1.0817 4.73E-02 5.08E-01 −0.8640 0.00E+00 0.00E+00 ψ
XAC0415 hrcC −0.2713 2.49E-01 8.27E-01 −0.4053 4.75E-03 1.78E-01 $
XAC0413 hrpB7 −1.2107 1.08E-02 2.74E-01 −0.6590 0.00E+00 0.00E+00 ψ
XAC0417 hpa2 −1.4130 8.33E-03 2.31E-01 −0.4610 4.40E-04 2.64E-02 $
XAC0400 hpaA −1.0585 2.76E-03 1.10E-01 −0.7763 9.74E-03 2.05E-01 $
XAC0414 hrcT −1.0474 1.10E-02 2.74E-01 −0.6800 0.00E+00 0.00E+00 ψ
† Consensus between RNA-seq and microarray16 genes (64%).
ξ Only RNA-seq 0 gene (0%).
ψ Only microarray 6 genes (24%).
$ Undetected 3 genes (12%).
The list of known T3SS hrp cluster genes along with the information about the log2FC, p-value and FDR value from RNA-seq and microarray experiments.
"Detected by" column assigns by which method the known hrp cluster gene is found to be significantly differentially expressed.
A B
Figure 5 Comparison of expression levels of genes encoding T3SS and effectors that are commonly detected by RNA-seq and
microarray. (A) Frequency histogram showing percent of genes deviating from the magnitude of FC quantified by RNA-seq with respect to
microarray for hrp gene cluster. Bin width of 0.2 is used. (B) Frequency histogram showing percentage of genes deviating from the magnitude of
FC quantified by RNA-seq with respect to microarray for the T3SS and effector genes. Bin width of 0.5 is used.
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Table 2 Summary of Type III effector genes detected by RNA-seq and microarray
Locus Tag Gene Symbol RNA-seq Microarray Detected by
log2FC p-value FDR log2FC p-value FDR
XAC0286 xopE −1.3432 1.21E-07 1.69E-05 −1.1813 0.00E+00 0.00E+00 †
XACb0011 avrXacE3 −0.9098 2.20E-04 1.51E-02 −1.6363 0.00E+00 0.00E+00 †
XAC0754 xopI −1.1830 5.40E-04 3.11E-02 −0.7287 0.00E+00 3.00E-05 †
XAC3085 xopK −2.1505 0.00E+00 0.00E+00 −1.7157 0.00E+00 0.00E+00 †
XAC2786 xopN −3.5117 0.00E+00 0.00E+00 −2.9897 0.00E+00 0.00E+00 †
XAC1208 xopP −1.1860 1.00E-05 6.20E-04 −0.7583 0.00E+00 0.00E+00 †
XAC0277 xopR −1.1202 6.00E-05 5.10E-03 −1.2360 0.00E+00 0.00E+00 †
XAC0543 xopX −3.0765 0.00E+00 0.00E+00 −3.4423 0.00E+00 0.00E+00 †
XAC3230 xopAI −1.4353 0.00E+00 0.00E+00 −1.1510 0.00E+00 0.00E+00 †
XAC2922 hrpW −2.0833 0.00E+00 0.00E+00 −2.7723 0.00E+00 0.00E+00 †
XAC4213 xopAD −0.8816 2.60E-04 1.68E-02 −0.3960 2.17E-02 2.72E-01 ξ
XAC4333 xopQ −0.6779 1.95E-02 3.51E-01 −1.1190 0.00E+00 0.00E+00 ψ
XAC0601 xopV −0.5197 5.44E-02 5.33E-01 −0.7367 0.00E+00 2.70E-04 ψ
XAC0076 avrBs2 −0.8632 1.79E-03 7.90E-02 −0.566 5.00E-05 3.53E-03 $
XAC3090 xopL −0.3402 2.58E-01 8.37E-01 −0.6040 0.00E+00 0.00E+00 ψ
XAC3224 xopE −0.5716 2.45E-02 3.85E-01 −0.2397 2.68E-02 4.48E-01 $
XAC2009 xopZ −0.6456 9.45E-03 2.56E-01 −0.4160 1.30E-04 9.38E-03 $
XAC3666 xopAK −0.2756 2.89E-01 8.59E-01 −0.2060 3.23E-01 9.82E-01 $
XACa0022 pthA1 0.0225 8.00E-01 9.80E-01 0.0790 6.69E-01 9.98E-01 $
XACa0039 pthA2 −0.4501 2.09E-01 7.97E-01 0.0413 8.25E-01 9.98E-01 $
XACb0015 pthA3 −1.1700 3.52E-03 1.28E-01 0.0723 7.13E-01 9.98E-01 $
XACb0065 pthA4 −0.3423 8.51E-01 1.00E+00 0.0315 7.23E-01 9.98E-01 $
† Consensus between RNA-seq and microarray 10 genes (45.5%).
ψ Only microarray 3 genes (13.6%).
ξ Only RNA-seq 1 genes (4.5%).
$ Undetected 8 genes (36.4%).
The list of known T3SS effector genes along with the information about the log2FC, p-value and FDR value derived from RNA-seq and microarray experiments.
"Detected by" column assigns by which method the following effector genes are found to be significantly differentially expressed.
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component of an integral membrane potassium-
transporting system [59], is down-regulated by a factor
of 3 (log2 FC of 1.6) according to RNA-seq, but, micro-
array could not capture this, as the probes for this gene
were missing on the chip. This shows the limitation of
microarray, where probes for all the genes need to be
defined while designing the chip. Furthermore, four
genes uniquely found by RNA-seq are involved in signal
transduction and gene regulation, i.e. XAC4116 encod-
ing a serine/threonine kinase, XAC1819 encoding a
tryptophan-rich sensory protein, and two regulatory
genes XAC3026, and XAC3363, whose function in citrus
canker disease development remain to be explored. Fur-
thermore, 21 genes (24%) are currently annotated as
hypothetical proteins (Additional file 1: Table S6).
Among them, four hypothetical proteins XAC0854,
XAC4131, XAC1203, and XACb0064 were predicted to
be T3SS secreted while 7 hypothetical proteins,
XAC3275, XAC3680, XAC1943, XAC0527, XAC0599,XAC0239, and XAC0755 were predicted to be Type 2
Secretion System (T2SS) substrates (Additional file 1:
Table S6) by Effective database [60]. Gram-negative bac-
teria employ T2SS to transport proteins to the extracellular
milieu, where the T2SS exo-proteins containing N-terminal
signal peptides are used for inner-membrane transloca-
tion through either the Sec translocon or the Tat com-
plex [61]. Genes encoding proteins secreted by T3SS and
T2SS have been experimentally proved to be regulated
by HrpX [33,62,63].
Among the 64 statistically significant differentially
expressed genes from microarray, 19 (29.7%) genes
were found to be uniquely detected by this method
(Additional file 2: Figure FS2). 18 were found to be
down-regulated, while one gene was up-regulated
(Additional file 1: Table S4). Unlike that of RNA-seq,
nearly 63% genes (12 of 19 unique) could pass the FC
cut-off threshold, but failed to pass the FDR threshold
by RNA-seq. The remaining 37% genes (7 of 19
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threshold. Furthermore, six genes were found to be
hypothetical. Among them XAC2876, XAC1241, and
XAC2370 were predicted as T2SS substrates. XAC1241
predicted as a T2SS substrate, shared 73% identity with
a putative secreted protein from X. campestris pv. vesi-
catoria strain 85–10. Another T2SS candidate
XAC2370 shared 95% identity with a secreted protein
from X. fuscans subsp. aurantifolii str. ICPB 10535.
XAC1124 shared 100% identity with MEKHLA domain
protein from X. axonopodis pv. punicae str. LMG 859
[33]. This domain is found in bacteria associated with
plants. It further shares similarity with the PAS do-
main and might be involved in light, oxygen, and
redox potential sensation [64].Comparison at the level of functional annotations of
genes
For comparison based on the biological function for the
differentially expressed genes from RNA-seq and micro-
array, we utilized the ClueGO to integrate the Gene
Ontology (GO) [65] terms and KEGG [66] pathway
terms and create a functionally organised GO/KEGG
network. Functional annotation with biological processes
category resulted in 13 (14.94%) genes found from clus-
ter for RNA-seq, while for microarray it was 12
(19.35%).
The ClueGO overview pie chart highlighted that sig-
nificant proportion of the genes differentially regulated
are involved in “protein secretion by the T3SS” by both
RNA-seq and microarray (Additional file 3: Figure FS3A
& D). Additionally, RNA-seq also identified genes
involved in “secretion activity by cell” as well as “single
organism catabolic process” (Additional file 3: Figure
FS3A). On the other hand, microarray highlighted the
genes involved in “protein transmembrane transport”,
“polycyclic aromatic hydrocarbon degradation” and “es-
tablishment of localization in cell” (Additional file 3:
Figure FS3D). Majority of the genes are involved in “bac-
terial secretion system”, as shown by both RNA-seq and
microarray. Also the differentially expressed genes are
found to be significantly involved in the “transport of
monovalent inorganic cation” (Additional file 3: Figure
FS3B) and “protein transport” (Additional file 3: FS3E).
Genes have also been found uniquely by microarray as
significantly involved in “polycyclic aromatic hydrocar-
bon degradation” (Additional file 3: Figure FS3E). Genes
from RNA-seq have been found to be involved in “ribofla-
vin metabolism” as well as “single organism catabolic
process” (Additional file 3: Figure FS3B). Further,
visualization of the functionally grouped annotation net-
work for the differentially regulated genes derived from
RNA-seq (Additional file 3: Figure FS3C) and microarray(Additional file 3: Figure FS3F) methods highlighted the
relationships between the terms. RNA-seq highlighted “pro-
tein secretion by the T3SS” along with the “small molecule
catabolic process”, while microarray reflected “polycyclic
aromatic hydrocarbon degradation” and “establishment of
localization in cell”, as the most significant terms of the
group. This analysis also showed that RNA-seq and micro-
array together provide more comprehensive functional in-
formation than the individual methods.
PIP box detection
HrpX is known to regulate the target gene expression by
specifically binding to PIP box motif present in the
cis-regulatory regions. PIP box consists of direct
repeats of “TTCGC” with a spacer of 8 to 26-bps in
between the repeats, even though ideally 8-bps and
15-bps are considered as the canonical PIP box [37].
We exploited this feature and looked for PIP boxes in
the promoter regions of the 106 significantly differen-
tially expressed genes (Additional file 4). All the 106
differentially expressed genes could be assigned to 90
transcriptional units based on MetaCyc database [67]
(Additional file 1: Table S8). However for simplicity,
genes under the control of the same cis-regulatory
regions were counted separately. Among the consensus
45 genes, 36 (80%) were shown to have canonical PIP
boxes (Figure 6A, Additional file 1: Table S7). Of the 42
genes that are uniquely determined by RNA-seq, 13
(31%) genes were confirmed to have PIP boxes; whereas,
among the 19 genes that are uniquely determined by
microarray 11 (57.8%) genes were confirmed to have PIP
boxes (Figure 6A, Additional file 1: Table S7).
In this study, we identified newly PIP box motif in 7
(19.4%) genes among consensus, 13 (100%) genes unique
to RNA-seq and 1 (9%) gene unique to microarray
(Figure 6B). Overall, 60 of the 106 (~57%) signifi-
cantly differentially expressed genes were confirmed to
have PIP boxes in their cis-regulatory regions (Add-
itional file 1: Table S7, Additional file 4). The pres-
ence of PIP box confirmed that these genes may be
directly regulated by HrpX, while the remaining 46
that do not have PIP boxes may be indirectly regu-
lated by HrpX via the other transcription factors. In
this regard, we looked for genes with sequence spe-
cific DNA binding activity in the 106 differentially
expressed genes. Six genes namely hrpG, pcaQ, blal,
XAC3026, XAC3445, and XAC3446 were known to
have sequence specific DNA binding activity according
to GO annotation. Among them, XAC3446, XAC3445,
and blaI have been newly identified in this study con-
taining PIP box motif (Additional file 1: Table S7,
Additional file 4). Thereby these 3 transcription regu-
lators are directly regulated by HrpX, which in turn
we assume regulate the 46 genes, which do not
A B
Figure 6 Statistics of HrpX binding sites in the cis-regulatory regions of significantly differentially expressed genes from RNA-seq and
microarray. The genes belonging to consensus and unique to each method are shown (A) Percentage of genes containing PIP box in the
cis-regulatory regions of genes that belong to three different groups are shown. The known (black bar) and novel (red bar) are indicated. (B) Only
genes with PIP box are shown, percentage of which already known (black bar) and novel (red bar) are indicated.
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lated by HrpX. The DNA binding signatures for many
of these transcription factors are unknown; hence, ob-
scure the further confirmation of regulation by these
transcription factors. Nevertheless, the fact that many
of the genes that were uniquely determined by each
method showed a clear PIP box in their cis-
regulatory regions reiterates that RNA-seq and micro-
array complement each other.
Discussion
Currently, RNA-seq is becoming the preferable choice
for gene expression profiling in place of microarrays.
Although, all the parameters that influence the various
aspects of this method are yet to be understood com-
pletely, RNA-seq undoubtedly is playing a very important
role in deciphering the complexity of the transcriptome
by giving a new direction to isoforms, allelic expression,
untranslated regions, splice junctions, antisense regula-
tion and intragenic expression [10,16,29,68-74]. Several
studies have begun to investigate on the parameters like
sequencing depth, precision, GC bias, length bias, lane
effects, and processing artifacts [16,29,48,75-77]. On the
other hand, microarrays are in usage for more than two
decades. Therefore, most of the biases inherent to this
method have become more apparent [78]. For instance,
biases in the hybridization of the samples labeled with
Cyanine5 (Cy5) and Cyanine3 (Cy3) are sufficiently
explored, and currently several approaches are practiced
to minimize such effects [79-82]. Further, systematic
variability like influence of the image scanner settings on
the dye intensity measurements have now been robustly
handled by applying various normalization techniques
[83-86]. Despite these developments, some inherentgenes–specific biases like differential hybridization
efficiencies of the labeled target transcript to the
same probe are still found to be inevitable in micro-
arrays. In RNA-seq as well as microarray, all these
known and unknown parameters influence the final
outcome. Therefore, in this study, we focused on the
assessment of RNA-seq and microarray based on the
final outcome .i.e. statistically significant differentially
expressed genes.
In comparison with previous RNA-seq studies, with a
sequence coverage of 97% we observed for our data set,
is in consistence with the reported 89.5% to 95% cover-
age observed in other bacterial RNA-seq studies [87-89].
In our study, RNA-seq has identified more significantly
differentially expressed genes (82%), when compared to
microarray (63%) as in previous studies [18,29,30]. The
overall correlation (rs 0.76) in the magnitudes of FC for
the consensus genes between the two methods was
found to be similar or higher than previous studies
[18,29,30,72]. Furthermore, our comparison analysis with
qRT-PCR suggested that the expression levels were
highly reliable for those genes that were determined to
be differentially expressed by both RNA-seq and micro-
array. Hence, confirming the differential expression of
genes by multiple methods reduces false positives
thereby enhances the biological discovery.
Even though microarray overall outperformed RNA-
seq by detecting more known HrpX target genes from
the T3SS in hrp cluster by satisfying both FC and FDR
cut-off threshold, in principle RNA-seq also detected
genes hrpB5, hrcS, hpaP, XAC0395, hrpB7, and hrcT, in
terms of FC, but failed to pass FDR threshold. This
parameter is more directly influenced by error model
considered in the statistical method that is used to
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itself. For the same read counts, one can get slightly
different FDR values depending on the statistical
method [90]. But the implementation of all the statis-
tical methods is not feasible for every dataset. From
the T3SS in hrp cluster, three genes namely, hrcC,
hpa2, and hpaA were not found to be detected by
both RNA-seq and microarray, mainly because they fail
to pass FDR threshold. Interestingly, our previous
microarray analysis confirmed that all these three
genes are regulated by HrpX, but only at a later stage
of the growth phase by satisfying both FC and FDR
cut-off thresholds [33]. This consolidates the regulation
of some of the genes at later stages of the growth
phase. Further, in case of Type III effector genes, 8
genes (36.4%) were not detected by both RNA-seq and
microarray within considered cut-off threshold limit.
However, among them xopL, avrBs2, xopAK and xopZ
were found to be regulated by HrpX only at the later
stage of the growth phase (OD600 time point 0.5),
according to our previous microarray analysis [33].
Further, four genes namely, pthA2, pthA1, pthA3,
pthA4 were regulated by another transcription regula-
tor HrpG at early stage of growth phase (OD600 =
0.25 and 0.4) as observed in our previous study, while
another undetected gene xopE was found to be also
regulated by HrpG, but only at OD600 = 0.25 time
point of growth phase [33]. Thereby this study further
validated our previous results. Subsequently, both
methods detected 100% of the genes known to be
regulated by HrpX (at time point OD600 = 0.4) without
any false positives. Among them, 72% were detected
by both the methods while interestingly 28% of the
known target genes were detected by either one of the
methods. Hence, both the methods together could
complement each other.
In addition 55 genes (~51%) were newly identified as
differentially expressed by applying both microarray as
well as RNA-seq methods, thereby adding up to the
already existing repertoire of HrpX regulated genes. Fur-
thermore, 46 (83.6%) genes among them were uniquely
identified by either one of the methods. Overall, 21
newly identified genes were found to have PIP box in
their promoter regions, wherein 14 (58.3%) genes were
uniquely identified by either RNA-seq or microarray.
The presence of the PIP box in the promoter regions of
the HrpX-regulated genes uniquely identified by RNA-
seq and microarray further not only confirmed that
these genes are directly regulated by HrpX, but also that
these candidates are not false positives. Consequently,
100% of the known HrpX regulated genes could only be
detected together by both the methods, since each
method missed out on some of the known genes; hence
both the methods together enhance the understandingof HrpX regulome by providing a more comprehensive
picture.
Conclusions
This study has significantly advanced our understanding
of the regulome of the critical transcriptional factor
HrpX and demonstrates that RNA-seq and microarray
complement each other in transcriptome profiling. Con-
sequently, our study demonstrates the advantage of ap-
plying multiple transcriptome profiling methods to
reveal a more comprehensive picture of a transcriptome,
rather than relying solely on one method.
Methods
Bacterial strains and growth conditions
The wild-type X. citri subsp. citri [32], and the hrpX mu-
tant strains used in this study were described in our pre-
vious study [33]. Both the strains were grown at 28°C in
nutrient broth (NB), on nutrient agar (NA), or in NYG
medium [91]. Antibiotics rifamycin and kanamycin were
added to the media at 50 μg/ml final concentrations.
RNA extraction
Total RNA was extracted from the wild-type and the
hrpX mutant strains as described in our previous study
[33]. Briefly, strains from NA plates were grown in NB
medium at 28°C until mid-exponential phase. Cultures
were harvested by centrifugation and inoculated in to
nutrient-deficient XVM2 medium, after washing the pel-
let once with the same medium. Cultures were finally
harvested for RNA extraction, when the optical density
at 600 nm reached the value of 0.4, and mixed immedi-
ately with RNAprotect bacterial reagent (Qiagen, Valen-
cia, CA, and U.S.A.). Total RNA was extracted from
each replicate separately using RiboPure bacteria kit
(Ambion, Austin, TX, USA), according to manufacturer’s
instructions. Genomic DNA contamination from the
extracted RNA samples was removed using TURBO
DNA-free kit (Ambion). Amount and the quality of the
RNA samples was initially determined using NanoDrop™
1000 spectrophotometer (NanoDrop Technologies, Inc.,
Wilmington, DE). Samples with absorbency at 260/280
and 260/230 nm ratios > 2 were subjected to further
processing. Three biological replicates of the wild-type
and the hrpX mutant samples were used for RNA-seq
analysis.
Microarray data
The microarray data used in this study was generated
during our previous study [33]. Three unique 60-mer
oligonucleotide probes were designed for each of the
4,427 protein coding genes of X. citri subsp. citri [33]. 8-
by-15-K DNA microarray chips covering the whole gen-
ome were implemented under the Agilent platform.
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ary Center for Biotechnology Research Microarray Core
Facility, University of Florida. The raw data is available
at National Center for Biotechnology Information
(NCBI) Gene Expression Omnibus (GEO) data reposi-
tory under the accession number GSE24016 [33].
mRNA enrichment and RNA-seq
Total RNA samples were enriched for mRNA, by depleting
rRNA using MICROBExpress kit from Ambion following
the manufacturer’s instructions. Enriched samples were
checked for integrity using Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). RNA
samples that passed the quality control were sequenced
using the Illumina Genome Analyzer IIx (GAIIx) system
by following the standard protocol at the Center for
Genome Analysis at Yale University. Real-time analysis
and base calling were performed using the CASAVA
v1.6 pipeline. The raw sequence data has been submit-
ted to the NCBI Sequence Read Archive and assigned
with an accession number SRA052842.
Reads mapping and statistical analysis
The X. citri subsp. citri whole genome sequence consisting
of one chromosome [GenBank: NC_003919.1], and two
plasmids [GenBank: NC_003921.3 and NC_003922.1],
along with the annotation information were downloaded
from NCBI repository (ftp://ftp.ncbi.nih.gov/genomes/
Bacteria/). Quality-filtered reads were aligned on to the
genome using CLC Genomics Workbench v4.7.2 (CLC
bio, Aarhus, Denmark). Reads uniquely aligned to each
gene were tabulated from each replicate separately. Differ-
entially expressed genes were estimated using DESeq
package [92], available under the open-source Bioconduc-
tor suite of programs [93]. DESeq is a powerful tool to es-
timate the variance in RNA-seq data and test for
differential expression [92]. As an input, DESeq accepts a
table of read counts for each gene from different biological
replicates, and estimates the differentially expressed genes
using negative binomial distribution [92]. Statistically sig-
nificant differentially expressed genes from both micro-
array and RNA-seq data were obtained by applying a cut-
off threshold of FDR ≤ 0.05 (5%) and an absolute log2
fold-change ≥ 0.6.
Bioinformatics analysis
Similarity searches were performed online using position-
specific iterative BLAST (PSI-BLAST) at NCBI site
against non-redundant protein database [94]. T3SS and
T2SS predictions were performed using Effective database
[60]. The promoter regions of the significantly differen-
tially expressed genes were retrieved manually using NCBI
genome browser to look for the presence of PIP boxes.
The differentially expressed genes were assigned to thetranscriptional units by referring to the MetaCyc database
[67]. Biological interpretation of the differentially expressed
genes was carried out using the ClueGO v1.5 [95], a
Cytoscape plug-in [96].
qRT-PCR
All the qRT-PCR assays were performed as detailed
elsewhere [33]. Briefly, gene-specific primers were
designed for the selected genes using PrimerQuestSM
from Integrated DNA technologies (IDT), Coralville,
Iowa (Additional file 1: Table S6). qRT-PCR experi-
ments were performed in triplicates, at least three
times for each gene using 7500 fast real-time PCR system
(Applied Biosystems, Foster City, CA, USA), using a
QuantiTect SYBR green RT-PCR kit (Qiagen) with simi-
lar results, by following the manufacturer’s instructions.
The relative fold change of target gene expression was
calculated using 16S rRNA as an endogenous control
with the formula 2–ΔΔCT [97].
Data availability
The raw RNA-seq data from this study is deposited at
the NCBI sequence read archive (http://www.ncbi.nlm.
nih.gov/Traces/sra/sra.cgi), under the accession number
SRA052842, while the raw microarray data is available at
the NCBI Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo) with the accession number GSE24016.
Additional files
Additional file 1: The following excel format file contains the
following 8 additional tables: Table S1: Summary of RNA-seq reads
from wild-type and hrpX mutant strains of X. citri subsp. citri. Table S2: List
of genes that are called by both RNA-seq and microarray. Table S3: List of
genes that are uniquely called by RNA-seq and microarray. Table S4: List
of statistically significant differentially expressed genes by RNA-seq and
microarray filtered by cut-off thresholds. Table S5: List of randomly
selected genes for the comparison with qRT-PCR from the statistically
significant differentially expressed genes from RNA-seq and microarray.
Table S6: Gene specific primers used in qRT-PCR experiment. Table S7:
Summary of bioinformatics analysis of statistically significant differentially
expressed genes to be part of Type III Secretion System (T3SS) and Type
II Secretion System (T2SS) along with the occurrence of PIP box. Table S8:
List of 90 transcriptional units from X. citri subsp. citri to which the 106
differentially regulated genes belong.
Additional file 2: Contains the following two additional figures,
Figure FS1: Venn diagram summarizing genes called by both
technologies, when comparison is carried out between the total currently
annotated open reading frames (ORFs) available transcripts from the
transcriptome of X. citri subsp. citri. Fold-change values are available from
RNA-seq (4323) and microarray (4349). Gene’s called by both
technologies are indicated by the overlap between the two circles. 4312
are found in consensus, while 11 and 37 are unique to RNA-seq and
microarray respectively. Figure FS2: Venn diagram summarizing genes
that are significantly differentially expressed determined by RNA-seq and
microarray. Gene’s common to both methods are indicated by the
overlap between the two circles.
Additional file 3: Figure FS3 - Comparison at the level of the
functional annotations of the significantly differentially expressed
genes from RNA-seq and microarray. GO term and KEGG pathway
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http://www.biomedcentral.com/1471-2164/13/629information enrichment analysis is shown for the genes from RNA-seq
(left panel) and microarray (right panel). The overview of the analysis is
shown in the form of pie chart for gene set from RNA-seq (A), and
microarray (D). The histogram shows the number of genes associated
with terms for the genes from RNA-seq (B) and microarray (E).
Significantly enriched terms are indicated with ’*’. The terms that are
functionally related are shown as a network with terms as nodes and
relatedness is indicated with thickness of the edges that is based on their
kappa score. The most significant term per group are shown for genes
from RNA-seq (C) and microarray (F).
Additional file 4: Figure FS4 - Snapshot of the PIP box motif
present in the cis-regulatory region of significantly differentially
expressed genes is shown in the context of the whole genome of X.
citri subsp. citri. The absolute position of each PIP box motif occurrence
is shown on the whole genome map along with the −10 ‘TATA’ regions
and the gene start site.
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